Surface

Global Steel Grating Market Report 2022: Demand from End-Use Industries & Government Initiatives Toward Infrastructure Development Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Lunedì, Agosto 29, 2022
Steel, Manufacturing, Carbon, Steel, Market development, Observation, Stair tread, Porter's five forces analysis, Fossil fuel, USD, Others, Ansoff Matrix, Investment, Geography, Electric power, SWOT, CAGR, Wastewater treatment, Risk, Fence, COVID-19, Growth, Industry, Metal fabrication, Retail, Risk management, Mining, Application, Surface, Fabrication, Chemical substance

The Global Steel Grating Market is segmented based on Material, Surface, Fabrication, Application, End Use, and Geography.

Key Points: 
  • The Global Steel Grating Market is segmented based on Material, Surface, Fabrication, Application, End Use, and Geography.
  • By Material, the market is classified into Stainless Steel Grating, Carbon Steel Grating, and Aluminum Steel Grating.
  • By Surface, the market is classified into Plain Steel Grating and Serrated Steel Grating.
  • By Fabrication, the market is classified into Welded Steel Grating, Swage Locked Grating, Press Locked Grating, Riveted Grating, and Close Mesh Steel Grating.

Surface Oncology to Participate in the Gilmartin Group Emerging Growth Company Showcase

Retrieved on: 
Mercoledì, Agosto 24, 2022
Novartis, CCR8, Tumor microenvironment, CD73, Surface, CD39, PVRIG, GlaxoSmithKline, GLOBE, IL-27, Investor, Webcast, Pharmaceutical industry

CAMBRIDGE, Mass., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Rob Ross, M.D., chief executive officer, will participate in a fireside chat at the virtual Gilmartin Group Emerging Growth Company Showcase on Wednesday, August 31, 2022 at 2:30 p.m.

Key Points: 
  • CAMBRIDGE, Mass., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Rob Ross, M.D., chief executive officer, will participate in a fireside chat at the virtual Gilmartin Group Emerging Growth Company Showcase on Wednesday, August 31, 2022 at 2:30 p.m.
  • A live webcast of the presentation may be accessed by visiting the Investors & Media section of the Surface Oncology website at https://investors.surfaceoncology.com/ .
  • In addition, a replay of the webcast will be available on the companys website following the presentation.
  • Surface Oncologyis an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment.

Surface Oncology to Participate in the 2022 Wedbush PacGrow Healthcare Conference

Retrieved on: 
Lunedì, Agosto 1, 2022
CD39, Novartis, GLOBE, IL-27, PVRIG, Tumor microenvironment, Conference, Webcast, Surface, GlaxoSmithKline, CCR8, CD73, Investor, Pharmaceutical industry

CAMBRIDGE, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Rob Ross, M.D., chief executive officer, will participate in a virtual panel discussion entitled, IOs Wide Open - Opportunity and Challenges in Immuno-Oncology at the 2022 Wedbush PacGrow Healthcare Conference.

Key Points: 
  • CAMBRIDGE, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Rob Ross, M.D., chief executive officer, will participate in a virtual panel discussion entitled, IOs Wide Open - Opportunity and Challenges in Immuno-Oncology at the 2022 Wedbush PacGrow Healthcare Conference.
  • The panel discussion will take place on Tuesday, August 9, 2022, at 8:00 am ET.
  • A live webcast of the discussion may be accessed by visiting the Investors & Media section of the Surface Oncology website at www.surfaceoncology.com .
  • Surface Oncologyis an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment.

Vyopta Expands Support for Zoom Phone and Zoom Rooms

Retrieved on: 
Martedì, Luglio 26, 2022
Investment, View, Product management, History, Poly, Meeting, Jabra, Multimedia, UC, Crestron Electronics, Technology, Microsoft, Organization, Dell, Cisco Systems, HP, Visibility, Camera, Satellite navigation device, Lenovo, Logitech, Zoom, Surface, Bose, Google, Web conferencing

AUSTIN, Texas, July 26, 2022 /PRNewswire/ -- Vyopta, the leader in digital collaboration and experience optimization, today announced expanded monitoring and analytics support for Zoom. The company has added Zoom Phone and Zoom Rooms to existing support for Zoom Meetings and Zoom Webinars. Since launching in January 2019, Zoom has added three million users to Zoom Phone through Q1 2022.

Key Points: 
  • The company has added Zoom Phone and Zoom Rooms to existing support for Zoom Meetings and Zoom Webinars.
  • Since launching in January 2019, Zoom has added three million users to Zoom Phone through Q1 2022.
  • For organizations transitioning to Zoom Phone or Zoom Rooms, Vyopta provides essential visualizations of usage by customer defined categories from all UC/collaboration platforms, making it easier to ensure a smooth adoption.
  • Learn more about Vyopta's support for Zoom Phone and Zoom Rooms: https://www.vyopta.com/product/what-we-cover/zoom/ .

Pluralsight Appoints Former Microsoft Executive Somit Goyal as President and Chief Operating Officer

Retrieved on: 
Martedì, Luglio 12, 2022
AOL, Technology, INSEAD, General manager, Indian Institutes of Technology, Software as a service, Artificial intelligence, Microsoft, CEO, COO, Government, Somite, Machine learning, SAP, Data science, Oracle, Growth, Surface, Electrical engineering, Industry, Institute, Management, Pluralsight, Marketing

SILICON SLOPES, Utah, July 12, 2022 /PRNewswire/ -- Pluralsight, the technology workforce development company, today announced the appointment of Somit Goyal as President and Chief Operating Officer (COO).

Key Points: 
  • SILICON SLOPES, Utah, July 12, 2022 /PRNewswire/ -- Pluralsight, the technology workforce development company, today announced the appointment of Somit Goyal as President and Chief Operating Officer (COO).
  • An exceptional leader and ultimate team player, I'm so excited to welcome Somit to Pluralsight."
  • I am thrilled with the opportunity to join Pluralsight and contribute to the company's mission of advancing the world's technology workforce," said Somit.
  • Somit comes to Pluralsight after spending more than a decade at Microsoft in various leadership roles, most recently as General Manager of Modern Work.

Surface Oncology Appoints Carsten Brunn to Board of Directors

Retrieved on: 
Mercoledì, Giugno 29, 2022
BIO, Lomb, University of Hamburg, IL-27, Annual report, Biotechnology Innovation Organization, Patient, CCR8, Federalisation of the European Union, Surface, University of Washington Department of Bioengineering, London Business School, Novartis, GLOBE, COVID-19, Bayer, Industry, PVRIG, Forward-looking statement, CD39, University, U.S. Securities and Exchange Commission, EFPIA, Risk, Cancer, European Federation of Pharmaceutical Industries and Associations, Security (finance), Private Securities Litigation Reform Act, Antibody, Bausch, Nasdaq, Eli Lilly, GlaxoSmithKline, Tumor microenvironment, Immune tolerance, Chemistry, Selecta, CD73, Doctor of Philosophy, Pharmaceutical industry

CAMBRIDGE, Mass., June 29, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Carsten Brunn, Ph.D., will join the companys board of directors.

Key Points: 
  • CAMBRIDGE, Mass., June 29, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Carsten Brunn, Ph.D., will join the companys board of directors.
  • I am thrilled to welcome Carsten to the Surface Oncology board, said Rob Ross, M.D., chief executive officer at Surface.
  • Dr. Brunn is president and chief executive officer at Selecta Biosciences (Nasdaq: SELB), a clinical stage precision immune tolerance platform company.
  • Dr. Brunn previously served on the board of directors of the Biotechnology Innovation Organization (BIO), and he was chairman of the European Federation of Pharmaceutical Industries and Associations (EFPIA) Japan.

Global Mining Automation Market to Reach $3.4 Billion by 2026

Retrieved on: 
Martedì, Giugno 28, 2022
Surface, Hexagon AB, Research, Autonomous Solutions, Intelligence, Marketing, COVID-19, Geography, Growth, Forecasting, Surface mining, Sandvik, Autonomy, GIA, Automation, SAN, Hitachi, CAGR, Caterpillar Inc., Trimble Inc., Volvo, Players, ASI, Heavy equipment, Pet, Others, Mining

SAN FRANCISCO, June 28, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Mining Automation - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, June 28, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Mining Automation - Global Market Trajectory & Analytics" .
  • Preview Registry
    Amid the COVID-19 crisis, the global market for Mining Automation estimated at US$2.5 Billion, is projected to reach a revised size of US$3.4 Billion by 2026, growing at a CAGR of 5.4% over the analysis period.
  • The U.S. Market is Estimated at $778.5 Million in 2021, While China is Forecast to Reach $598.9 Million by 2026
    The Mining Automation market in the U.S. is estimated at US$778.5 Million in the year 2021.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.

Global Industry Analysts Predicts the World Geospatial Analytics Market to Reach $112.5 Billion by 2026

Retrieved on: 
Giovedì, Giugno 23, 2022
CAGR, SAP, DigitalGlobe, General Electric Company, COVID-19, Harris Corporation, Players, Software, Hexagon AB, Intelligence, Structured Geospatial Analytic Method, Forecasting, Trimble Inc., Geographic data and information, GIA, Research, Growth, Vernor v. Autodesk, Inc., Marketing, Internet, Google, Marvell Software Solutions Israel, Surface, Solution, SAP SE, Bentley Systems, Mobile location analytics, Oracle Corporation, Orbital Insight, SAN, Maxar Technologies, Renewable energy, Pet, Others, Geovisualization, Esri, Service

SAN FRANCISCO, June 23, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Geospatial Analytics - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, June 23, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Geospatial Analytics - Global Market Trajectory & Analytics" .
  • Preview Registry
    Amid the COVID-19 crisis, the global market for Geospatial Analytics estimated at US$46.2 Billion, is projected to reach a revised size of US$112.5 Billion by 2026, growing at a CAGR of 15.8% over the analysis period.
  • The U.S. Market is Estimated at $16.2 Billion in 2021, While China is Forecast to Reach $19.7 Billion by 2026
    The Geospatial Analytics market in the U.S. is estimated at US$16.2 Billion in the year 2021.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.

Surface Oncology Announces Publication of New Study Demonstrating the Role of the IL-27 Pathway in Hepatocellular Carcinoma

Retrieved on: 
Lunedì, Giugno 20, 2022
GlaxoSmithKline, Association, NK, Security (finance), FDA, American Association, COVID-19, HCC, CD73, Safety, Annual report, PVRIG, Tumor microenvironment, Cedars-Sinai Medical Center, U.S. Securities and Exchange Commission, Fox Chase Cancer Center, Liver cancer, Cancer, CD39, Forward-looking statement, Fast Track, Private Securities Litigation Reform Act, Fatty liver disease, Novartis, Immunotherapy, Surface, AACR, Hepatocellular carcinoma, NASH, IL-27, Patient, Bevacizumab, CCR8, GLOBE, Prevalence, Orphan drug, Mouse, Risk, Pharmaceutical industry, American Association for Cancer Research

CAMBRIDGE, Mass., June 20, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that findings from a study interrogating the role of the IL-27 pathway in the development of hepatocellular carcinoma (HCC) have been published in the online edition of Cancer Discovery, a journal of the American Association for Cancer Research (AACR). The study was conducted by Cedars-Sinai Medical Center and Fox Chase Cancer Center in collaboration with Surface.

Key Points: 
  • The study was conducted by Cedars-Sinai Medical Center and Fox Chase Cancer Center in collaboration with Surface.
  • The study also demonstrated that pharmacological neutralization of IL-27 using an antibody developed by Surface led to increased NK and innate immune cell activation and reduced HCC development.
  • HCC is the most common form of liver cancer and characterized by a poor survival rate and limited treatment options.
  • Surface Oncology is an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment.

TCL CSOT Wins Two Prestigious iF Design Awards

Retrieved on: 
Lunedì, Giugno 13, 2022
Backlight, International Forum Design, Surface, TCL Technology, Multimedia, Google Cloud Print, TCL, Human, OLED, Television, View, Curve, Technology

SHENZHEN, China, June 13, 2022 /PRNewswire/ --TCL CSOT, a company committed to innovation in display technology, recently won two honors at the International Forum (iF) Design Awards 2022.

Key Points: 
  • SHENZHEN, China, June 13, 2022 /PRNewswire/ --TCL CSOT, a company committed to innovation in display technology, recently won two honors at the International Forum (iF) Design Awards 2022.
  • The awards were given to the TCL Surface Television and the TCL Zhezhi Television, both equipped with the world's narrowest bezel of 0.3mm.
  • The yearly awards are one of the most prestigious accolades rendered for product design in the world and have been held in Germany since 1953.
  • The two products from TCL CSOT will now benefit from carrying the iF logo, which highlights the outstanding design and is seen as a badge of quality among consumers and the design community.